氨酸:瘤转移的一个潜在驱动因素
Yuening Li1, Yiming Sun2, Kun Yu2
1Army Medical University, Chongqing, China.
International journal of biological macromolecules
|March 6, 2025
概括
质蛋白对于上皮细胞结构和瘤进展至关重要. 向质素可以通过抑制瘤细胞迁移和入侵来对抗癌症转移.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 质蛋白是上皮细胞中关键的中间丝蛋白,对细胞结构至关重要.
- 在上皮癌中,异常的质蛋白表达是常见的,与瘤进展相关.
- 质素会影响多种转移性过程,如免疫逃避和血管生成.
研究的目的:
- 突出质素在增强瘤细胞迁移和入侵中的重要作用.
- 强调质素是瘤转移的关键驱动因素.
- 为了强调在癌症治疗中准质素的治疗潜力.
主要方法:
- 对表皮细胞和瘤中的角质素功能的现有研究进行审查.
- 对将质蛋白表达与瘤进展和转移联系起来的研究进行分析.
- 综合证据证明质素对细胞迁移和侵入的影响.
主要成果:
- 质素显著提高瘤细胞的迁移和入侵能力.
- 质素被确定为瘤转移的关键驱动因素.
- 氨酸的作用扩展到机械力反应,免疫逃避,代谢重编程,血管生成和亡抵抗.
结论:
- 质蛋白在驱动瘤转移方面起着关键作用.
- 向质蛋白是一种有前途的治疗策略,可以对抗癌症转移.
- 进一步了解质素的作用可能会带来新的癌症治疗机会.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


